Alkermes Plc (NASDAQ:ALKS)

63.33
Delayed Data
As of Mar 27
 +0.39 / +0.62%
Today’s Change
38.49
Today|||52-Week Range
75.17
+8.15%
Year-to-Date

Today’s Trading

Previous close62.94
Today’s open61.33
Day’s range61.33 - 63.73
Volume1,436,594
Average volume (3 months)1,550,320
Market cap$9.4B
Dividend yield--
Data as of 4:14pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-185.04%
Earnings growth (next 5 years)+72.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales13.75
Price/Book6.69

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...+0.44+0.81%
MDVNMedivation Inc+3.62+2.82%
JAZZJazz Pharmaceuticals...+2.03+1.17%
UTHRUnited Therapeutics ...+5.44+3.25%
Data as of 4:02pm ET, 03/27/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$618.8M
Annual profit (last year)-$30.1M
Net profit margin-4.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account